PMID: 11930647Apr 5, 2002Paper

Management of nephropathy in patients with type 2 diabetes

Chinese Medical Journal
Julian A J H CritchleyClive S Cockram

Abstract

To review evidence-based management of nephropathy in patients with type 2 diabetes. A literature search (MEDLINE 1966 to 2000) was performed using the key word "diabetic nephropathy". Relevant book chapters were also reviewed. Well-controlled, prospective landmark studies and expert review articles on diabetic nephropathy were selected. Data and conclusions from the selected articles that provide solid evidence to the optimal management of diabetic nephropathy were extracted and interpreted in light of our clinical research experience with many thousands of Hong Kong Chinese patients. Hypertension, long diabetes duration, poor glycaemic control and central obesity are the most important risk factors. Microalbuminuria is a practical marker to predict overt nephropathy in type 2 diabetic patients. Risk factor modification, renal function monitoring and combined therapies are the current integrated approaches to manage patients with diabetic kidney disease. Optimal glycaemic control is the mainstay of treatment but effective antihypertensive therapy is also key to delaying the progression of diabetic nephropathy. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists have important renoprotective actions...Continue Reading

Citations

Mar 31, 2012·International Journal of Cardiology·Roberta PolettiMichele Emdin
May 12, 2009·The Medical Clinics of North America·Nitin KhoslaGeorge L Bakris
Feb 13, 2007·Journal of the American College of Cardiology·Colin BerryMartial G Bourassa
Jul 27, 2006·Progress in Cardiovascular Diseases·Ehud Grossman, Franz H Messerli
Jul 14, 2010·Translational Research : the Journal of Laboratory and Clinical Medicine·Maria KamperElli F Kamper
Sep 5, 2006·Seminars in Nephrology·Jerome Rossert, Marc Froissart
Jan 8, 2013·The Medical Clinics of North America·Peter N Van Buren, Robert D Toto
Oct 18, 2008·American Heart Journal·M Angelyn BethelJohn McMurray
Dec 28, 2007·Diabetes Research and Clinical Practice·Swarna VarmaGretchen A Piatt
May 1, 2008·Journal of the American Society of Hypertension : JASH·Ronald D SmithCarlos M Ferrario
Apr 28, 2004·Trends in Endocrinology and Metabolism : TEM·Louise M BurrellMark E Cooper
Nov 25, 2011·International Journal of Cardiology·Tadashi KonoshitaUNKNOWN Genomic Disease Outcome Consortium (G-DOC) Study Investigators
Nov 29, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Peggy W G du Buf-VereijkenJack F M Wetzels
Nov 30, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Maria Elena ManniLaura Raimondi
Aug 22, 2012·The American Journal of Medicine·Anil K BidaniMurray Epstein
Feb 8, 2005·Cardiology Clinics·Kris Vijayaraghavan, Prakash C Deedwania
Mar 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Allan J CollinsThomas J Arneson
Mar 1, 2005·The Nursing Clinics of North America·Ken W Edmisson
May 2, 2014·Advances in Chronic Kidney Disease·Hala YamoutGeorge L Bakris
Jun 27, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Martin MacKinnonHeather D Clark
Jan 8, 2013·The Medical Clinics of North America·Jamie P Dwyer, Julia B Lewis
Dec 20, 2005·Disease-a-month : DM·John Brian Copley, Reinaldo Rosario
Aug 17, 2010·Diabetes Research and Clinical Practice·Yasuaki HayashinoUNKNOWN CAP-KD study group
Mar 28, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Gerald SchulmanNelson Kopyt
Jan 8, 2013·The Medical Clinics of North America·Mark E Williams
Jun 18, 2019·Diabetes, Obesity & Metabolism·John A HollandCarel W le Roux
Jan 11, 2018·Diabetes/metabolism Research and Reviews·Angelo AvogaroIldiko Lingvay
Oct 26, 2005·The Journal of Small Animal Practice·G F Grauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

The New England Journal of Medicine
T Vandor
The New England Journal of Medicine
C MoraJ F Navarro
The New England Journal of Medicine
D M Grace
Journal of the Chinese Medical Association : JCMA
Hai-Lu ZhaoPaul Chan
The New England Journal of Medicine
Eberhard Ritz, S R Orth
© 2022 Meta ULC. All rights reserved